A national panel of 15 mesothelioma specialists across surgery, medical oncology, radiation oncology, and pathology reached a consensus and issued new guidelines for surgery. The experts reviewed 116 studies and data from 630 mesothelioma surgeries between 2015 and 2025. After three rounds of formal voting, the panel challenged reluctance to[…]
Surgery
Frequent Collapsed Lung Indicates Mesothelioma
A new article highlights the link between a collapsed lung and mesothelioma. Mesothelioma, caused by asbestos exposure, can present unexpectedly. It often requires many clinical tests for accurate diagnosis and treatment planning. A new study explores the case of a 73-year-old whose recurrent collapsing lung was found to be mesothelioma.[…]
Limited Surgery to Limit Symptoms of Pleural Mesothelioma
A new clinical trial at the University of Chicago is testing whether a smaller, symptom-focused surgery can help pleural mesothelioma patients maintain quality of life when tumor removal is not possible. This study looks at surgery differently compared to other trials. Rather than focusing first on complete tumor removal, it[…]
PITAC to Treat Mesothelioma
A Stanford team performed a specialized procedure for pleural mesothelioma for the very first time in North America. It is known as pressurized intrathoracic aerosol chemotherapy (PITAC), and it delivers chemotherapy directly to the chest as a pressurized mist. One doctor knows it as “spray paint chemo.” PITAC is minimally[…]
Pleurectomy/Decortication Surgery Has Low Mortality When Patients are Carefully Selected
A new study out of the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds lung-sparing pleurectomy/decortication (P/D) surgery has a very low rate of early mortality. These findings are in direct contrast to those from the MARS2 trial, which reported P/D surgery carried[…]
Multimodal Therapy to Treat Mesothelioma
Malignant pleural mesothelioma is a significant health challenge for individuals. Mesothelioma is linked to asbestos exposure and demands innovative treatment strategies. Recent research provides a promising approach to combatting mesothelioma. A multimodal treatment regimen could offer hope and improved outcomes for people battling the disease. A multimodal approach consists of[…]
Surgery and Improved Mesothelioma Survival
Pleural mesothelioma is a rare and aggressive cancer. The cancer with a poor prognosis is mainly caused by asbestos. Surgery is an important part of treating pleural mesothelioma, but the impact of surgery on patients’ survival is unclear and sparking debate. A recent study was presented at the World Conference[…]
Opdivo and Yervoy Before and After Surgery and a New Blood Test are Improving Mesothelioma Treatment
Researchers are reporting promising results for people with mesothelioma who can have surgery. One researcher tested immunotherapy before and after surgery while the other researcher studied a blood test that helps doctors detect mesothelioma earlier than scans. Doctors at several cancer centers, including Johns Hopkins, ran an early clinical trial[…]
Empyema Challenges After Pleural Mesothelioma Surgery
Pleural mesothelioma, a cancer linked to asbestos exposure, is very tough to treat. Surgery is one part of multimodal therapy that aims to remove as much cancer as possible. Surgery is a very useful tool in the treatment of mesothelioma, but after surgery, complications can occur. One complication can be[…]
Multimodal Therapy to Treat Pleural Mesothelioma
Malignant pleural mesothelioma is a deadly cancer that is mainly caused by asbestos exposure. It affects the lungs’ lining. It is a very hard to treat cancer because it is very aggressive and is often diagnosed at a late stage. New surgical and therapeutic methods are offering hope though. A[…]
Skip to content